부산대학교 도서관

de Graaff, Marieke A ; Yu, Jamie S E ; Beird, Hannah C ; Ingram, Davis R ; Nguyen, Theresa ; Juehui Liu, Jeffrey ; Bolshakov, Svetlana ; Szuhai, Károly ; Åman, Pierre ; Torres, Keila E ; Lev, Dina ; Nielsen, Torsten O ; Bovée, Judith V M G ; Lazar, Alexander J ; Somaiah, Neeta

In Laboratory Investigation August 2016 96(8):885-894

Fang, Hong; Wang, Sa A; Beird, Hannah C; Tang, Zhenya; You, M James; Li, Shaoying; Xu, Jie; Hu, Shimin; Yin, C Cameron; Hussein, Siba El; Lin, Pei; Jelloul, Fatima Zahra; Vega, Francisco; Medeiros, L Jeffrey; Wang, Wei

American Journal of Clinical Pathology. Dec2024, Vol. 162 Issue 6, p582-590. 9p.

Beird, Hannah C; Lin, Dimitri; Lazar, Alexander J; Futreal, P Andrew

Journal of Pathology; Jun2024, Vol. 263 Issue 2, p131-134, 4p

Wu, Chia-Chin; Huang, Licai; Zhang, Zhongting; Ju, Zhenlin; Song, Xingzhi; Kolb, E Anders; Zhang, Wendong; Gill, Jonathan; Ha, Min; Smith, Malcolm A; Houghton, Peter; Morton, Christopher L; Kurmasheva, Raushan; Maris, John; Mosse, Yael; Lu, Yiling; Gorlick, Richard; Futreal, P Andrew; Beird, Hannah C

Sci Rep
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)

Devarajan, Eswaran; Davis, R Eric; Beird, Hannah C; Wang, Wei-Lien; Jensen, V Behrana; Jayakumar, Arumugam; Leung, Cheuk Hong; Lin, Heather Y; Wu, Chia-Chin; Ihezie, Stephanie A; Tsai, Jen-Wei; Futreal, P Andrew; Lewis, Valerae O

Discov Oncol
Discover Oncology, Vol 15, Iss 1, Pp 1-14 (2024)

Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Cloutier JM; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Gokgoz N; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital Toronto, Ontario, Canada.; Eeles C; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Griffin AM; University of Toronto Musculoskeletal Oncology Unit, Division of Orthopaedic Surgery, Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada.; Ingram DR; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wani KM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Segura RL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Cohen L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Ho C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wunder JS; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital Toronto, Ontario, Canada; University of Toronto Musculoskeletal Oncology Unit, Division of Orthopaedic Surgery, Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada.; Andrulis IL; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital Toronto, Ontario, Canada; Department of Molecular Genetics Canada, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Haibe-Kains B; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Vector Institute for Artificial Intelligence, Toronto, Ontario, Canada.; Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Przybyl J; Department of Surgery, McGill University & Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.; Demicco EG; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada. Electronic address: Elizabeth.demicco@sinaihealth.ca.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0376617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0307 (Electronic) Linking ISSN: 00236837 NLM ISO Abbreviation: Lab Invest Subsets: MEDLINE

Wang L; Departments of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Wang W; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Beird HC; Departments of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Cheng X; Departments of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Fang H; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Tang G; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Toruner GA; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Yin CC; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; You MJ; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Issa GC; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Borthakur G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Peng G; Departments of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Khoury JD; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Medeiros LJ; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Tang Z; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101551097 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4425 (Electronic) Linking ISSN: 20734425 NLM ISO Abbreviation: Genes (Basel) Subsets: MEDLINE

Lamhamedi-Cherradi SE; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. SLamhamedi@mdanderson.org.; Maitituoheti M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Menegaz BA; Department of Surgery, Breast surgical Oncology, Baylor College of Medicine, Houston, TX, 77030, USA.; Krishnan S; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Vetter AM; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Camacho P; Texas Children's Cancer & Hematology Centers, Houston, TX, 77384, USA.; Wu CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Porter RW; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Ingram DR; Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Ramamoorthy V; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Mohiuddin S; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; McCall D; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Truong DD; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Cuglievan B; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Futreal PA; Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Velasco AR; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Anvar NE; Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Utama B; Optical Microscopy Facility, Rice University, Houston, TX, 77030, USA.; Titus M; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Lazar AJ; Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Wang WL; Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Rodriguez-Aguayo C; Experimental Therapeutics Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Ratan R; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Livingston JA; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Rai K; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. Krai@mdanderson.org.; MacLeod AR; Ionis Pharmaceuticals, Carlsbad, CA, 92010, USA.; Daw NC; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Hayes-Jordan A; Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, NC, 27599, USA.; Ludwig JA; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jaludwig@mdanderson.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Nakazawa MS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Silverman IM; Repare Therapeutics, Cambridge, Massachusetts.; Rimkunas V; Repare Therapeutics, Cambridge, Massachusetts.; Veloso A; Repare Therapeutics, Cambridge, Massachusetts.; Glodzik D; Repare Therapeutics, Cambridge, Massachusetts.; Johnson A; Repare Therapeutics, Cambridge, Massachusetts.; Ohsumi TK; Repare Therapeutics, Cambridge, Massachusetts.; Patel SR; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Roland CL; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wu CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Ingram DR; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lazcano R; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Song D; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wani KM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lazar AJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Yap TA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Livingston JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

Wu CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lamhamedi-Cherradi SE; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Soeung M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ingram D; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Truong DD; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Porter RW; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Krishnan S; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Little L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Titus M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Genovese G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ludwig JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lazar AJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hayes-Jordan A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. andrea_hayes-jordan@med.unc.edu.; Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. afutreal@mdanderson.org.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Somaiah, Neeta; Beird, Hannah C; Barbo, Andrea; Song, Juhee; Mills Shaw, Kenna R.; Wang, Wei-Lien; Eterovic, Karina; Chen, Ken; Lazar, Alexander; Conley, Anthony P.; Ravi, Vinod; Hwu, Patrick; Futreal, Andrew; Simon, George; Meric-Bernstam, Funda; Hong, David

Oncotarget

Abbas HA; Division of Cancer Medicine, Medical Oncology Fellowship, University of Texas M D Anderson Cancer Center, Houston, TX, USA.; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hao D; Division of Cancer Medicine, Medical Oncology Fellowship, University of Texas M D Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.; Tomczak K; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.; Barrodia P; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.; Im JS; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Reville PK; Division of Cancer Medicine, Medical Oncology Fellowship, University of Texas M D Anderson Cancer Center, Houston, TX, USA.; Alaniz Z; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang W; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang R; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.; Wang F; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.; Al-Atrash G; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Takahashi K; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.; Ning J; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ding M; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Statistics, Rice University, Houston, TX, USA.; Beird HC; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.; Mathews JT; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Little L; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.; Zhang J; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.; Basu S; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Konopleva M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Marques-Piubelli ML; Department Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Solis LM; Department Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Parra ER; Department Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lu W; Department Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tamegnon A; Department Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Green MR; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA.; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sharma P; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Allison JP; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kornblau SM; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rai K; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA. KRai@mdanderson.org.; Wang L; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA. lwang22@mdanderson.org.; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. lwang22@mdanderson.org.; Daver N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA. NDaver@mdanderson.org.; Futreal A; Department of Genomic Medicine, University of Texas M D Anderson Cancer Center, Houston, TX, USA. AFutreal@mdanderson.org.; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. AFutreal@mdanderson.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Kochat V; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Raman AT; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, TX, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Landers SM; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tang M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Schulz J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Terranova C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Landry JP; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Louisiana State University School of Medicine, New Orleans, LA, USA.; Bhalla AD; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wu CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jiang Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mao X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lazcano R; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gite S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ingram DR; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yi M; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Keung EZ; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Scally CP; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Roland CL; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hunt KK; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feig BW; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hwu P; Department of Melanoma Medical Oncology and Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Wang WL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lazar AJ; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Slopis JM; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wilson-Robles H; Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, USA.; Wiener DJ; Department of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Science, Texas A&M University, College Station, TX, USA.; McCutcheon IE; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wustefeld-Janssens B; Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, USA.; Department of Surgical Oncology, Flint Animal Cancer Center, Colorado State University, Fort Collins, CO, USA.; Rai K; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. krai@mdanderson.org.; Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, TX, USA. krai@mdanderson.org.; Torres KE; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. KETorres@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. KETorres@mdanderson.org.; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. KETorres@mdanderson.org.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE

Fang H; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang W; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; El Hussein S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morita K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mitra A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Quantitative Sciences Graduate Training Program, Graduate School of Biomedical Sciences, Houston, TX, USA.; Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lin P; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Khoury JD; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Estecio M; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hardikar S; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bannon SA; Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Khoury JD; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Routbort M; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gong T; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kondo K; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chen T; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101265293 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2308 (Electronic) Linking ISSN: 15592294 NLM ISO Abbreviation: Epigenetics Subsets: MEDLINE

Beird, Hannah C; Wu, Chia-Chin; Nakazawa, Michael; Ingram, Davis; Daniele, Joseph R; Lazcano, Rossana; Little, Latasha; Davies, Christopher; Daw, Najat C; Wani, Khalida; Wang, Wei-Lien; Song, Xingzhi; Gumbs, Curtis; Zhang, Jianhua; Rubin, Brian; Conley, Anthony; Flanagan, Adrienne M; Lazar, Alexander J; Futreal, P Andrew

HGG Adv
HGG Advances, Vol 4, Iss 4, Pp 100224-(2023)

Fang H; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ibrahim AF; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA.; Tang Z; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; You MJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hu S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Xu J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Li S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yin CC; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; El Hussein S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Le N; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Thakral B; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Thornton R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Little L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang W; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. wwang13@mdanderson.org.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Khlebus E; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Vuttaradhi VK; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Welte T; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Khurana N; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Celestino J; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Little L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Legarreta AF; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Fellman BM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Nguyen T; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lawson B; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Ferri-Borgogno S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Mok SC; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Broaddus RR; Department of Pathology and Laboratory Medicine, The University of North Carolina, Chapel Hill, North Carolina.; Gershenson DM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Hillman RT; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; CPRIT Scholar in Cancer Research, Houston, Texas.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

Wu CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Andrew Livingston J; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Advani S; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mitra A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cao S; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Reuben A; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ingram D; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ju Z; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hong Leung C; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lin H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zheng Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Roszik J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang W; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel S; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Benjamin RS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mills GB; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hwu P; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gorlick R; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lazar A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Daw NC; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lewis V; Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. afutreal@mdanderson.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Khan M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang F; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Alfayez M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cai T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhao L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Khoury J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. npemmaraju@mdanderson.org.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE